BONESUPPORT HOLDING AB (BOEUF)
25.15
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.656B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -10.18% |
| Valuation | |
| PE Ratio | 85.43 |
| PE Ratio (Forward) | |
| PS Ratio | 13.01 |
| Price to Book Value | 16.81 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.015 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 63.10% |
Profile
| BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden. |
| URL | http://www.bonesupport.com |
| Investor Relations URL | N/A |
| HQ State/Province | Skane |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Jul. 16, 2026 |
| Last Earnings Release | Apr. 22, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden. |
| URL | http://www.bonesupport.com |
| Investor Relations URL | N/A |
| HQ State/Province | Skane |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | Jul. 16, 2026 |
| Last Earnings Release | Apr. 22, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |